Intestinal Research

Cancer
Korean Guidelines for Postpolypectomy Colonoscopic Surveillance: 2022 revised edition (6,271 times): Su Young Kim, Min Seob Kwak, Soon Man Yoon, Yunho Jung, Jong Wook Kim, Sun-Jin Boo, Eun Hye Oh, Seong Ran Jeon, Seung-Joo Nam, Seon-Young Park, Soo-Kyung Park, Jaeyoung Chun, Dong Hoon Baek, Mi-Young Choi, Suyeon Park, Jeong-Sik Byeon, Hyung Kil Kim, Joo Young Cho, Moon Sung Lee, Oh Young Lee, Korean Society of Gastrointestinal Endoscopy, Korean Society of Gastroenterology, Korean Association for the Study of Intestinal Diseases; Intest Res. 2023;21(1):20-42. Published online January 31, 2023; DOI: https://doi.org/10.5217/ir.2022.00096
Crossref 8; Full text PubReader ePub PDF Supplementary Material

IBD
Sarcopenia is common in ulcerative colitis and correlates with disease activity (3,576 times): Pardhu B Neelam, Rimesh Pal, Pankaj Gupta, Anupam K Singh, Jimil Shah, Harshal S Mandavdhare, Harjeet Singh, Aravind Sekar, Sanjay K Bhadada, Usha Dutta, Vishal Sharma; Intest Res. 2024;22(2):162-171. Published online January 22, 2024; DOI: https://doi.org/10.5217/ir.2023.00090
Web of Science 3 Crossref 3; Full text PubReader ePub PDF Supplementary Material

Endoscopy
Use of device-assisted enteroscopy in small bowel disease: an expert consensus statement by the Korean Association for the Study of Intestinal Diseases (5,330 times): Han Hee Lee, Jin Su Kim, Hyeon Jeong Goong, Shin Hee Lee, Eun Hye Oh, Jihye Park, Min Cheol Kim, Kwangwoo Nam, Young Joo Yang, Tae Jun Kim, Seung-Joo Nam, Hee Seok Moon, Jae Hyun Kim, Duk Hwan Kim, Seong-Eun Kim, Seong Ran Jeon, Seung-Jae Myung, The Small Intestine Research Group of the Korean Association for the Study of Intestinal Diseases (KASID); Intest Res. 2023;21(1):3-19. Published online January 31, 2023; DOI: https://doi.org/10.5217/ir.2022.00108
Crossref 3; Full text PubReader ePub PDF

IBD
Efficacy and safety of mirikizumab as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a subgroup analysis of the global phase 3 LUCENT-1 and LUCENT-2 studies (2,842 times): Taku Kobayashi, Katsuyoshi Matsuoka, Mamoru Watanabe, Tadakazu Hisamatsu, Fumihito Hirai, Joe Milata, Xingyuan Li, Nathan Morris, Vipin Arora, Tomoko Ishizuka, Koji Matsuo, Yoichi Satoi, Catherine Milch, Toshifumi Hibi; Intest Res. 2024;22(2):172-185. Published online April 25, 2024; DOI: https://doi.org/10.5217/ir.2023.00043; Full text PubReader ePub PDF Supplementary Material

Tumor
Pathogenesis and biomarkers of colorectal cancer by epigenetic alteration (3,205 times): Chang Kyo Oh, Young-Seok Cho; Intest Res. 2024;22(2):131-151. Published online February 1, 2024; DOI: https://doi.org/10.5217/ir.2023.00115; Full text PubReader ePub PDF

Screening and surveillance for hereditary colorectal cancer (2,295 times): Hee Man Kim, Tae Il Kim; Intest Res. 2024;22(2):119-130. Published online February 6, 2024; DOI: https://doi.org/10.5217/ir.2023.00112; Full text PubReader ePub PDF

IBD
Assessing quality of magnetic resonance enterography and its impact on disease assessment of ileal Crohn’s disease (2,484 times): Anuj Bohra, Declan J Connoley, Danny Con, Jonathan P Segal, Olga Niewiadomski, Abhinav Vasudevan, Daniel R Van Langenberg, Numan Kutaiba; Intest Res. 2024;22(2):152-161. Published online January 5, 2024; DOI: https://doi.org/10.5217/ir.2023.00095
Web of Science 3 Crossref 3; Full text PubReader ePub PDF Supplementary Material

Functional bowel disorder
An evaluation of dietary adequacy among patients with constipation-predominant irritable bowel syndrome in Malaysia (6,431 times): Nor Hamizah Shafiee, Nurul Huda Razalli, Norfilza M. Mokhtar, Eunice Tan, Raja Affendi Raja Ali; Intest Res. 2022;20(1):124-133. Published online January 22, 2021; DOI: https://doi.org/10.5217/ir.2020.00050
Web of Science 7 Crossref 8; Full text PubReader ePub PDF

IBD, Infection
Durability and outcomes of fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with moderate to severe inflammatory bowel disease (2,270 times): Raseen Tariq, Edward V Loftus Jr, Darrell Pardi, Sahil Khanna; Intest Res. 2024;22(2):208-212. Published online January 9, 2024; DOI: https://doi.org/10.5217/ir.2023.00100; Full text PubReader ePub PDF Supplementary Material

IBD
Achieving high-quality magnetic resonance enterography is critical for assessing Crohn’s disease activity (1,632 times): Kyoung Doo Song; Intest Res. 2024;22(2):117-118. Published online April 25, 2024; DOI: https://doi.org/10.5217/ir.2024.0043; Full text PubReader ePub PDF

Tumor
Unraveling molecular similarities between colorectal polyps and colorectal cancer: a systems biology approach (2,439 times): Mehran Radak, Hossein Fallahi; Intest Res. 2024;22(2):199-207. Published online February 6, 2024; DOI: https://doi.org/10.5217/ir.2023.00162
Web of Science 1 Crossref 1; Full text PubReader ePub PDF Supplementary Material

IBD
Animal models of inflammatory bowel disease: novel experiments for revealing pathogenesis of colitis, fibrosis, and colitis-associated colon cancer (4,363 times): Chan Hyung Lee, Seong-Joon Koh, Zaher A Radi, Aida Habtezion; Intest Res. 2023;21(3):295-305. Published online May 31, 2023; DOI: https://doi.org/10.5217/ir.2023.00029
Web of Science 11 Crossref 13; Full text PubReader ePub PDF

Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease (6,269 times): Himani Pandey, Dheeraj Jain, Daryl W. T. Tang, Sunny H. Wong, Devi Lal; Intest Res. 2024;22(1):15-43. Published online November 8, 2023; DOI: https://doi.org/10.5217/ir.2023.00080
Web of Science 5 Crossref 3; Full text PubReader ePub PDF

Tumor
A survey of current practices in post-polypectomy surveillance in Korea (1,251 times): Jeongseok Kim, Tae-Geun Gweon, Min Seob Kwak, Su Young Kim, Seong Jung Kim, Hyun Gun Kim, Eun Ran Kim, Sung Noh Hong, Eun Sun Kim, Chang Mo Moon, Dae Seong Myung, Dong Hoon Baek, Shin Ju Oh, Hyun Jung Lee, Ji Young Lee, Yunho Jung, Jaeyoung Chun, Dong-Hoon Yang, on behalf of the Intestinal Tumor Research Group of the Korean Association for the Study of Intestinal Diseases (KASID); Intest Res. 2024;22(2):186-207. Published online April 25, 2024; DOI: https://doi.org/10.5217/ir.2023.00109; Full text PubReader ePub PDF Supplementary Material

IBD
Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis (7,612 times): Soo-Young Na, Chang Hwan Choi, Eun Mi Song, Ki Bae Bang, Sang Hyoung Park, Eun Soo Kim, Jae Jun Park, Bora Keum, Chang Kyun Lee, Bo-In Lee, Seung-Bum Ryoo, Seong-Joon Koh, Miyoung Choi, Joo Sung Kim, on behalf of the IBD Research Group of the Korean Association for the Study of Intestinal Diseases; Intest Res. 2023;21(1):61-87. Published online May 31, 2022; DOI: https://doi.org/10.5217/ir.2022.00007
Web of Science 21 Crossref 24; Full text PubReader ePub PDF Supplementary Material

Use of thiopurines in inflammatory bowel disease: an update (8,617 times): Arshdeep Singh, Ramit Mahajan, Saurabh Kedia, Amit Kumar Dutta, Abhinav Anand, Charles N. Bernstein, Devendra Desai, C. Ganesh Pai, Govind Makharia, Harsh Vardhan Tevethia, Joyce WY Mak, Kirandeep Kaur, Kiran Peddi, Mukesh Kumar Ranjan, Perttu Arkkila, Rakesh Kochhar, Rupa Banerjee, Saroj Kant Sinha, Siew Chien Ng, Stephen Hanauer, Suhang Verma, Usha Dutta, Vandana Midha, Varun Mehta, Vineet Ahuja, Ajit Sood; Intest Res. 2022;20(1):11-30. Published online April 15, 2021; DOI: https://doi.org/10.5217/ir.2020.00155
Web of Science 45 Crossref 47; Full text PubReader ePub PDF

Update on the epidemiology of inflammatory bowel disease in Asia: where are we now? (6,020 times): Sang Hyoung Park; Intest Res. 2022;20(2):159-164. Published online April 29, 2022; DOI: https://doi.org/10.5217/ir.2021.00115
Web of Science 39 Crossref 40; Full text PubReader ePub PDF

Treatment of primary sclerosing cholangitis combined with inflammatory bowel disease (4,060 times): You Sun Kim, Edward H. Hurley, Yoojeong Park, Sungjin Ko; Intest Res. 2023;21(4):420-432. Published online September 1, 2023; DOI: https://doi.org/10.5217/ir.2023.00039
Web of Science 4 Crossref 3; Full text PubReader ePub PDF

Serum albumin is the strongest predictor of anti-tumor necrosis factor nonresponse in inflammatory bowel disease in resource-constrained regions lacking therapeutic drug monitoring (3,555 times): Peeyush Kumar, Sudheer K. Vuyyuru, Prasenjit Das, Bhaskar Kante, Mukesh Kumar Ranjan, David Mathew Thomas, Sandeep Mundhra, Pabitra Sahu, Pratap Mouli Venigalla, Saransh Jain, Sandeep Goyal, Rithvik Golla, Shubi Virmani, Mukesh K. Singh, Karan Sachdeva, Raju Sharma, Nihar Ranjan Dash, Govind Makharia, Saurabh Kedia, Vineet Ahuja; Intest Res. 2023;21(4):460-470. Published online March 17, 2023; DOI: https://doi.org/10.5217/ir.2022.00128
Web of Science 1 Crossref 2; Full text PubReader ePub PDF Supplementary Material

Microbiota
The role of microbiome in colorectal carcinogenesis and its clinical potential as a target for cancer treatment (7,460 times): Sang Hoon Kim, Yun Jeong Lim; Intest Res. 2022;20(1):31-42. Published online May 21, 2021; DOI: https://doi.org/10.5217/ir.2021.00034
Web of Science 25 Crossref 25; Full text PubReader ePub PDF

Most view